The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8933228, 13 ID: ALA3695586
PubChem CID: 54766344
Max Phase: Preclinical
Molecular Formula: C28H27Cl2N7O4
Molecular Weight: 596.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c(Cl)c2Cl)cc1
Standard InChI: InChI=1S/C28H27Cl2N7O4/c1-28(2,3)20-14-21(37(35-20)15-6-8-16(40-5)9-7-15)33-26(38)32-17-10-11-18(23(30)22(17)29)41-19-12-13-31-25-24(19)36(4)27(39)34-25/h6-14H,1-5H3,(H,31,34,39)(H2,32,33,38)
Standard InChI Key: UUDAKQZBMTXFJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 45 0 0 0 0 0 0 0 0999 V2000
16.9037 5.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0806 4.6517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6199 4.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5895 3.9062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1302 4.2535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7038 5.6862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7318 6.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1911 6.4337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2760 6.1485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8026 7.5719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3027 7.5615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8490 6.1317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0685 5.2803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0758 3.7795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7803 3.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7379 3.6165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7876 1.5211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4920 0.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1903 1.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8939 0.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4032 -4.1625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4916 -3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2007 -1.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2049 -2.6909 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.4972 -0.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5385 -1.3328 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.4136 8.7674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8934 9.8674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2212 8.6334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7011 9.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
13 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 2 0
29 31 1 0
31 32 1 0
31 33 1 0
33 23 1 0
33 27 2 0
21 34 1 0
34 35 1 0
34 36 2 0
36 18 1 0
36 37 1 0
11 38 1 0
38 39 1 0
38 40 1 0
38 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 596.48Molecular Weight (Monoisotopic): 595.1502AlogP: 6.50#Rotatable Bonds: 6Polar Surface Area: 128.09Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: 10.41CX Basic pKa: 4.14CX LogP: 6.37CX LogD: 6.37Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.21Np Likeness Score: -1.29
References 1. (2015) Respiratory formulations and compounds for use therein,